Opening Asia for Russia

India approves nasal vaccine against covid manufactured by Bharat Biotech

07.09.2022 ТАСС 128 просмотров

Recombinant nasal vaccine ChAd36-SARS-CoV-S COVID-19 is the first approved nasal vaccine against coronavirus in India.


A nasal vaccine against coronavirus infection produced by the Indian company Bharat Biotech was approved on Tuesday in India. This was announced by the Minister of Health and Family Welfare of India Mansukh Mandavia on his Twitter page.

"The recombinant nasal vaccine ChAd36-SARS-CoV-S COVID-19 (chimpanzee vector adenovirus) from Bharat Biotech has been approved by the Central Organization for Drug Standards Control (CDSCO) for primary immunization against COVID-19 in the 18+ age group for limited use in an emergency situation," the minister wrote.

The new drug is the first nasal coronavirus vaccine approved in India. "This step will strengthen our collective fight against COVID-19," Mansukh Mandavia said.

Новости партнёров